Samuel D. Rabkin

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

James M. Markert, Michael D. Medlock, Samuel D. Rabkin et al. · Gene Therapy · 2000 · 971 citations

Neuro-oncology, Cancer-associated Virus, Glioma +8

Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells

Mario L. Suvà, Esther Rheinbay, Shawn Gillespie et al. · Cell · 2014 · 920 citations · Full text

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

Toshihiro Mineta, Samuel D. Rabkin, Takahito Yazaki et al. · Nature Medicine · 1995 · 817 citations

Neuro-oncology, Herpes Simplex Virus–1, Cancer-associated Virus +12

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

Dipongkor Saha, Robert L. Martuza, Samuel D. Rabkin · Cancer Cell · 2017 · 588 citations · Full text

Neuro-oncology, Tumor Immunology, Cancer Immunosurveillance +13

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin et al. · Proceedings of the National Academy of Sciences · 2001 · 452 citations · Full text